This site is intended for Healthcare Professionals only.

Class 2 recall for Olopatadine eye drops

Date:

Share post:

The Medicines and Healthcare products Regulatory Agency has issued a class 2 medicines recall notice for Olopatadine USV 1mg/ml eye drops.

Specific batches of this product are being recalled by USV UK Limited as a precautionary measure due to the identification of out of specification results for impurities during routine stability testing.

USV UK Limited are recalling the affected batches as a precautionary measure due to out of specification results for impurities during routine stability testing.

Batch Number Expiry Date Pack Size First Distributed
35000201 07/2023 5ml 14 July 2021
35000202 07/2023 5ml 27 July 2021
35000203 07/2023 5ml 5 August 2021
35000204 07/2023 5ml 29 November 2021
35000206 07/2023 5ml 23 July 2021

 

While the company’s investigation is on-going, community pharmacy contractors should stop supplying the specified batches immediately, quarantine all remaining stock, and return it to their supplier using their supplier’s approved process.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Pharmacist Support seeks 2 dedicated trustees to expand impact

The pharmacist charity values diversity and encourages individuals of all backgrounds to apply for trustee positions In a recent...

Pharmacy closure Skyrockets:177 businesses closed this year, warns NPA

Rising costs and declining real terms funding led to the fastest rate of pharmacy closures in decades The...

Pharmacy First service described as ‘slow’, ‘challenging’ and ‘underfunded’

Contractors also highlighted the importance of improving GPs’ understanding of Pharmacy First service  Pharmacy owners discussed the key concerns...

‘I care deeply about the future of our community pharmacies,’ says Rishi Sunak

The UK prime minister also recognised the need to invest in health infrastructure across the country   Responding to...